Ahmed Abdelhakeem

635 total citations
22 papers, 91 citations indexed

About

Ahmed Abdelhakeem is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Epidemiology. According to data from OpenAlex, Ahmed Abdelhakeem has authored 22 papers receiving a total of 91 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 7 papers in Epidemiology. Recurrent topics in Ahmed Abdelhakeem's work include Gastric Cancer Management and Outcomes (10 papers), Esophageal Cancer Research and Treatment (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Ahmed Abdelhakeem is often cited by papers focused on Gastric Cancer Management and Outcomes (10 papers), Esophageal Cancer Research and Treatment (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Ahmed Abdelhakeem collaborates with scholars based in United States, Pakistan and Japan. Ahmed Abdelhakeem's co-authors include Manal M. Hassan, Rikita Hatia, Asif Rashid, Donghui Li, Ahmed O. Kaseb, Jaffer A. Ajani, Mariela Blum Murphy, Prasun K. Jalal, Carrie R. Daniel and Yun Shin Chun and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Annals of Surgery.

In The Last Decade

Ahmed Abdelhakeem

17 papers receiving 90 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahmed Abdelhakeem United States 6 30 28 23 22 20 22 91
Malene Hornbak Denmark 7 17 0.6× 14 0.5× 15 0.7× 40 1.8× 31 1.6× 11 119
Fei Xiao China 6 57 1.9× 16 0.6× 13 0.6× 10 0.5× 32 1.6× 11 108
Xuetao Shi China 6 10 0.3× 23 0.8× 22 1.0× 17 0.8× 14 0.7× 18 86
Danny Orabi United States 7 8 0.3× 29 1.0× 25 1.1× 31 1.4× 22 1.1× 10 91
Elnaz Naderi Netherlands 7 12 0.4× 9 0.3× 20 0.9× 28 1.3× 21 1.1× 14 97
Yuki Nakagami Japan 7 27 0.9× 26 0.9× 36 1.6× 11 0.5× 13 0.7× 17 82
Jérôme Bourgault Canada 8 12 0.4× 36 1.3× 8 0.3× 64 2.9× 31 1.6× 16 135
Kornelius Schulze Germany 4 15 0.5× 17 0.6× 14 0.6× 14 0.6× 9 0.5× 7 50
Béla Pikó Hungary 5 19 0.6× 9 0.3× 59 2.6× 5 0.2× 17 0.8× 20 89

Countries citing papers authored by Ahmed Abdelhakeem

Since Specialization
Citations

This map shows the geographic impact of Ahmed Abdelhakeem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed Abdelhakeem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed Abdelhakeem more than expected).

Fields of papers citing papers by Ahmed Abdelhakeem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmed Abdelhakeem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed Abdelhakeem. The network helps show where Ahmed Abdelhakeem may publish in the future.

Co-authorship network of co-authors of Ahmed Abdelhakeem

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmed Abdelhakeem. A scholar is included among the top collaborators of Ahmed Abdelhakeem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmed Abdelhakeem. Ahmed Abdelhakeem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdelhakeem, Ahmed, et al.. (2025). Pancreatic ductal adenocarcinoma (PDAC): clinical progress in the last five years. Expert Opinion on Investigational Drugs. 34(3). 149–160. 7 indexed citations
2.
3.
Abdelhakeem, Ahmed, Jeremy Jones, Caitlin B. Conboy, et al.. (2025). Safety and efficacy analysis of modified TOPAZ-1: A biweekly regimen of gemcitabine and cisplatin plus monthly durvalumab in advanced biliary tract cancer.. Journal of Clinical Oncology. 43(16_suppl).
4.
Arslan, Hafiz Muhammad, et al.. (2024). Immunotherapy Responses in Viral Hepatitis-Induced HCC: A Systematic Review and Meta-Analysis. Current Oncology. 31(11). 7204–7225. 1 indexed citations
5.
Sewastjanow‐Silva, Matheus, Kohei Yamashita, Ahmed Abdelhakeem, et al.. (2024). Three biomarkers ( HER2 , PD‐L1 , and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience. International Journal of Cancer. 155(12). 2277–2286. 2 indexed citations
6.
Sarfraz, Zouina, et al.. (2024). Impact of socioeconomic status on cancer care in Southeast Texas: a retrospective population-based cohort study. Baylor University Medical Center Proceedings. 37(5). 782–793. 3 indexed citations
7.
Abdelhakeem, Ahmed, et al.. (2024). Survival Outcomes in Stage IV Gastric Cancer Patients with Krukenberg Tumors: A Systematic Review and Meta Analysis. Journal of Gastrointestinal Cancer. 55(3). 1004–1025.
8.
Waters, Rebecca, Matheus Sewastjanow‐Silva, Kohei Yamashita, et al.. (2024). Retrospective Study of Claudin 18 Isoform 2 Prevalence and Prognostic Association in Gastric and Gastroesophageal Junction Adenocarcinoma. JCO Precision Oncology. 8(8). e2300543–e2300543. 11 indexed citations
9.
Abdelhakeem, Ahmed, et al.. (2024). Survival outcomes in patients with stage IV gastric cancer with Krukenberg tumors: A systematic review and meta-analysis.. Journal of Clinical Oncology. 42(16_suppl). e16020–e16020.
10.
Hatia, Rikita, Ernest T. Hawk, Ahmed Shalaby, et al.. (2023). Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma. Cancer Epidemiology Biomarkers & Prevention. 32(10). 1338–1347. 2 indexed citations
11.
Charalampakis, Nikolaos, Dimitriοs Schizas, Stylianos Kykalos, et al.. (2022). Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives. World Journal of Gastrointestinal Oncology. 14(1). 181–202. 4 indexed citations
12.
Abdelhakeem, Ahmed & Mariela Blum Murphy. (2022). Adjuvant Therapies for Esophageal Cancer. Thoracic surgery clinics/Thorac. surg. clin.. 32(4). 457–465. 5 indexed citations
13.
Abdelhakeem, Ahmed, Xuemei Wang, Rebecca Waters, et al.. (2021). Preoperatively Treated Diffuse-Type Gastric Adenocarcinoma: Glucose vs. Other Energy Sources Substantially Influence Prognosis and Therapy Response. Cancers. 13(3). 420–420. 1 indexed citations
14.
Abdelhakeem, Ahmed, Madhavi Patnana, Xuemei Wang, et al.. (2021). Influence of Baseline Positron Emission Tomography in Metastatic Gastroesophageal Cancer on Survival and Response to Therapy. Oncology. 99(10). 659–664. 2 indexed citations
15.
Day, R. Sue, Ruosha Li, Xianglin L. Du, et al.. (2021). Dietary Patterns and Hepatocellular Carcinoma Risk among US Adults. Nutrients. 13(6). 2011–2011. 12 indexed citations
16.
Zheng, Jiali, Carrie R. Daniel, Rikita Hatia, et al.. (2021). Dietary N‐Nitroso Compounds and Risk of Hepatocellular Carcinoma: A USA‐Based Study. Hepatology. 74(6). 3161–3173. 15 indexed citations
17.
Day, R. Sue, Ruosha Li, Ahmed O. Kaseb, et al.. (2021). Association of dietary fat intake and hepatocellular carcinoma among US adults. Cancer Medicine. 10(20). 7308–7319. 12 indexed citations
18.
Harada, Kazuto, Hyunsoo Hwang, Xuemei Wang, et al.. (2019). Frequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma. Annals of Surgery. 273(4). 751–757. 9 indexed citations
19.
Abdelhakeem, Ahmed, Ahmed O. Kaseb, Rikita Hatia, et al.. (2019). Distribution of insulin growth factor-1 (IGF-1) binding proteins in hepatocellular carcinoma with and without cirrhosis.. Journal of Clinical Oncology. 37(4_suppl). 193–193. 1 indexed citations
20.
Harada, Kazuto, Ahmed Abdelhakeem, & Jaffer A. Ajani. (2018). A balancing act: dual immune-checkpoint inhibition for oesophagogastric cancer. Nature Reviews Clinical Oncology. 16(1). 9–10. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Malene Hornbak Breakdown of academic impact, for papers by Fei Xiao Breakdown of academic impact, for papers by Xuetao Shi Breakdown of academic impact, for papers by Danny Orabi Breakdown of academic impact, for papers by Elnaz Naderi Breakdown of academic impact, for papers by Yuki Nakagami Breakdown of academic impact, for papers by Jérôme Bourgault Breakdown of academic impact, for papers by Kornelius Schulze Breakdown of academic impact, for papers by Béla Pikó
Rankless by CCL
2026